CAPTRUST FINANCIAL ADVISORS - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,000
-66.7%
108
-58.6%
0.00%
Q1 2022$9,000
-71.9%
261
-76.4%
0.00%
Q4 2021$32,000
+28.0%
1,106
+15.0%
0.00%
Q3 2021$25,000
-16.7%
962
+11.1%
0.00%
Q2 2021$30,000
-16.7%
866
-2.0%
0.00%
Q1 2021$36,000
+227.3%
884
+233.6%
0.00%
Q4 2020$11,000
-21.4%
265
+6.0%
0.00%
Q3 2020$14,000
-22.2%
2500.0%0.00%
Q2 2020$18,000
-53.8%
250
-68.9%
0.00%
-100.0%
Q3 2019$39,000
-7.1%
805
+0.8%
0.00%
-50.0%
Q2 2019$42,0007990.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders